Jan 08, 2024 / 05:45PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan, and we're delighted to be continuing the 42nd Annual Healthcare Conference today with Alnylam. I'm joined by the company's CEO, Yvonne Greenstreet. She's going to give a presentation. And then afterwards, we're going to move into Q&A. If you want to ask a question in the room, someone will bring you a mic. If you want to submit a question over the portal, you can do that as well. But very happy to hear Alnylam today. So I'll turn it over to you.
Yvonne L. Greenstreet - Alnylam Pharmaceuticals, Inc. - CEO & Director
Thank you, Jessica. It's a real pleasure to be here presenting on behalf of Alnylam in what we expect to be a milestone year for our company.
I'm Yvonne Greenstreet and I'm CEO of Alnylam, and I'm very pleased to be joined up here on stage by Pushkal Garg, our Chief Medical Officer; Jeff Poulton, our Chief Financial Officer; and Tolga Tanguler, our Chief Commercial.
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers